Atherosclerosis

Preclinical Diagnosis and Risk Assessment of Atherosclerosis - At Birth? At Event? When is Best?

Giuseppe Gullace, Hassan Khalaf

Editor's choice

The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease

Sven M Francque

European Cardiology Review, 2014;9(1):10–5

Videos

Latest articles

Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker

Maki Komiyama, Hiromichi Wada, Hajime Yamakage, et al

European Cardiology Review 2017;12(2):92–111.

DOI: .15420/ecr.2017:23:1
Inflammation Revisited: Atherosclerosis in The Post-CANTOS Era

Wolfgang Koenig

European Cardiology Review 2017;12(2):89–91.

DOI: .15420/ecr.2017:18:1
Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial

Jakub Podolec, Lukasz Niewiara

US Cardiology Review 2017;11(1):18–9

DOI: .15420/usc.11.1.GE
Optical Coherence Tomography For the Detection of the Vulnerable Plaque

Konstantinos Toutouzas, Antonios Karanasos, Dimitris Tousoulis, et al

European Cardiology Review 2016;11(2):90–5

DOI: .15420/ecr.2016:29:2